Nolu review
Every line came down a month apart, and every line is labeled per four weeks by the seller itself.
The verdict
Nolu publishes $199 per four weeks for injected semaglutide, $239 for the tablet and $279 for tirzepatide. Thirteen cycles a year make those $216, $259 and $302 a calendar month.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection · Oral
- Dose pricing
- Flat across doses
- Injection
- From $216/mo
- Oral
- From $259/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
Nolu sells both molecules by injection and semaglutide as a tablet. Every line is priced against a four-week cycle rather than a calendar month, and the pricing page says so.
Who writes the prescription, and what do they see?
A prescription precedes shipping. The pages state rates and cycles rather than describing who writes the prescription or how often a case is reviewed.
Labeling the cycle honestly is the disclosure most sellers skip, and Nolu makes it on all three lines. The arithmetic is still left to the reader.
What happens when the dose goes up?
The rates are recorded as flat across doses. A four-week cycle is the variable that moves instead, because thirteen of them arrive in a year rather than twelve.
What the price includes
A year of injected semaglutide is $2,587 rather than the $2,388 twelve payments would suggest. The tablet is $3,107 and tirzepatide $3,627. All three figures fell — by $50, $40 and $60 — so any older quote is now high.
What it claims, and what it cites
All three lines are compounded rather than manufactured. A pharmacy prepares them, and the FDA does not review a compounded preparation before dispensing.
Where it holds up, and where it does not
- Strength: The four-week cycle is labeled plainly
- Strength: All three lines came down
- Strength: Flat across doses on every line
- Strength: A tablet route is priced separately
- Limitation: Thirteen cycles a year, not twelve
- Limitation: Each figure reads about 8% low
- Limitation: No milligram published on any line
- Limitation: The states served are not recorded
What the evidence says about this kind of treatment
The assessment above is about Nolu. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who counts cycles rather than months and wants a flat rate at any dose.
- Wrong for
- A reader comparing $199 against another seller's calendar-month figure.
The evidence behind what Nolu prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How Nolu compares
| Seller | Who it suits | Go |
|---|---|---|
 Roboclinic | Readers ready to commit a full year and wanting the discount that buys | See Roboclinic → |
 SkinnyRx | Readers choosing tirzepatide, the one line with a published standing rate | See SkinnyRx → |
 Try Ageless | Readers willing to price the same product twice before buying it once | See Try Ageless → |
More GLP-1 telehealth sellers reviews: NuviaRxObu HealthOmnia TeleHealthOmzoOndra HealthRaeliva
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- What does a calendar month cost?
- $216, $259 and $302 across the three lines, once thirteen cycles a year are counted.
- Did the prices change?
- All three fell a month apart, by $50, $40 and $60.
- Does a higher dose cost more?
- No. The rates are recorded as flat across doses.
- Is Nolu expensive compared with other GLP-1 telehealth sellers?
- Nolu publishes a starting figure of $216/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Nolu above the median. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.